NGUYEN, THI PHUONG NHUNG
NGUYEN, THI PHUONG NHUNG
100008 - Dipartimento di medicina sperimentale
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction
2023-01-01 Raffaele, S.; Bonifacino, T.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli., M.
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation
2023-01-01 Raffaele, Stefano; Nguyen, Nhung; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Mannella, Francesca C.; Lambertsen, Kate L.; Madsen, Kirsten; Schroeder, Henrik D.; Hejbøl, Eva K.; Bonanno, Giambattista; Abbracchio, Maria P.; Bonifacino, Tiziana; Fumagalli, Marta
Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS
2021-01-01 Bonifacino, T; Raffaele, S; Nguyen, N; Milanese, M; Bonanno, G; Abbracchio, Mp; Fumagalli, M
In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
2022-01-01 Nguyen, Nhung; Milanese, M.; Raffaele, S.; Zerbo, R. A.; Fumagalli, M.; Abbracchio, M. P.; Bonanno, G.; Bonifacino, T.
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
2022-01-01 Bonifacino, T.; Nguyen, T. P. N.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M.
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity
2024-01-01 Bonifacino, T.; Raffaele, S.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli, M.
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity
2023-01-01 Bonifacino, Tiziana; Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Marta, Boccazzi; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria Pia, ; Marta, Fumagalli
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis
2022-01-01 Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria, Pia; Bonifacino, Tiziana; Fumagalli, Marta
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction | 1-gen-2023 | Raffaele, S.; Bonifacino, T.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli., M. | |
| A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation | 1-gen-2023 | Raffaele, Stefano; Nguyen, Nhung; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Mannella, Francesca C.; Lambertsen, Kate L.; Madsen, Kirsten; Schroeder, Henrik D.; Hejbøl, Eva K.; Bonanno, Giambattista; Abbracchio, Maria P.; Bonifacino, Tiziana; Fumagalli, Marta | |
| Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS | 1-gen-2021 | Bonifacino, T; Raffaele, S; Nguyen, N; Milanese, M; Bonanno, G; Abbracchio, Mp; Fumagalli, M | |
| In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis | 1-gen-2022 | Nguyen, Nhung; Milanese, M.; Raffaele, S.; Zerbo, R. A.; Fumagalli, M.; Abbracchio, M. P.; Bonanno, G.; Bonifacino, T. | |
| In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis | 1-gen-2022 | Bonifacino, T.; Nguyen, T. P. N.; Raffaele, S.; Frumento, G.; Milanese, M.; Abbracchio, M. P.; Bonanno, G.; Fumagalli, M. | |
| Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity | 1-gen-2024 | Bonifacino, T.; Raffaele, S.; Nguyen, N.; Boccazzi, M.; Frumento, G.; Milanese, M.; Bonanno, G.; Abbracchio, M. P.; Fumagalli, M. | |
| Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity | 1-gen-2023 | Bonifacino, Tiziana; Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Marta, Boccazzi; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria Pia, ; Marta, Fumagalli | |
| Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis | 1-gen-2022 | Raffaele, Stefano; Nguyen, THI PHUONG NHUNG; Boccazzi, Marta; Frumento, Giulia; Milanese, Marco; Bonanno, Giambattista; Abbracchio Maria, Pia; Bonifacino, Tiziana; Fumagalli, Marta |